/
/
/

Hester Biosciences Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)2,271.00
Volume (₹)312.00
High (₹)2,299.00
Upper Circuit2,717.80
Low (₹)2,269.80
Lower Circuit1,812.00
Prev Close2,264.90
52W High (₹)2,683.60
Price2,271.00
52W Low (₹)1,239.30

Share Market Cap & Key Ratios Overview

M.Cap (₹)1948.03 Cr
Div. Yield (%)0.48
PE Ratio14.31
Debt to Equity0.52
Price to Book2.98
Book Value423.46
EPS (TTM)160.08
Face Value10.00
ROE (%)17.05

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
MANKINDNSE
HESTERBIONSE
LTP
1W Low
1W High
Market cap (₹)
1843.2-17.8 (-0.96%)
1834
1856.80
4,41,957Cr
9256.5-182 (-1.93%)
9252
9415
2,47,576Cr
4915.5-14.5 (-0.29%)
4894
4988
1,89,233Cr
1119.8+2 (0.18%)
1104.60
1135.50
1,11,671Cr
1355.7-17.6 (-1.28%)
1347.70
1373
1,10,273Cr
1951.6+6.6 (0.34%)
1918.10
1981.80
1,06,460Cr
1161.7+18.7 (1.64%)
1130
1182
96,906Cr
1671.5+3.1 (0.19%)
1655.50
1688
96,402Cr
2085.3+7.5 (0.36%)
2058
2108.50
95,843Cr
2274+35.6 (1.59%)
2222
2291.30
94,050Cr
2271-8 (-0.35%)
2238.30
2299
1,948Cr

Key Highlights of Hester Biosciences Ltd Balance Sheet

Hester Biosciences Ltd balance sheet discloses shareholders' funds of ₹8.51Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹8.51Cr, and the reserves and surplus of the company is ₹376.68Cr.

The company has its non-current liabilities with total liabilities of ₹557.35Cr as of 2026-03-31.

The current liabilities are ₹91.92Cr as of 2026-03-31. At the same time, current assets are ₹189.76Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹64.28Cr and tangible assets of ₹288.01Cr, provided in the Hester Biosciences Ltd financial statements.